Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Fromkin Andrew J.
Over the trailing 90 days, Fromkin Andrew J. (Director at Immunovant, Inc.) traded $9.1M of stock (net selling $5.8M) in IMVT, per 10 SEC Form 4 transactions.
- Role
- Director
- Companies
- IMVT
- Window
- Trailing 90 days · 10 transactions · CIK 1341896
- Net activity
- −$5.8M ($1.6M bought · $7.4M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | 10 | $1.6M | $7.4M | −$5.8M |
Transactions (10)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-28 | IMVT | Buy | 31.7K | $158K | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Sell | 31.7K | $0 | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Buy | 16.3K | $239K | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Sell | 16.3K | $0 | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Sell | 77.2K | $0 | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Sell | 11.5K | $375K | Open market or private sale |
| 2026-05-28 | IMVT | Sell | 71.5K | $0 | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Buy | 77.2K | $651K | Exercise or conversion of derivative security |
| 2026-05-28 | IMVT | Sell | 210.5K | $7.1M | Open market or private sale |
| 2026-05-28 | IMVT | Buy | 71.5K | $568K | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Fromkin's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.